3 Ways That Payers Leveraged Artificial Intelligence in 2020
Payers used artificial intelligence to drive towards key objectives in 2020. Artificial intelligence is not a new technology, with the [...]
Aligning HEOR/RWE Procurement with Finance
Procurement is a business function that offers so much in the way of value. However, its not always easy to [...]
State Level Action in Response to ICER’s Unsupported Price Increase Report
In ICER’s latest report on Unsupported Price Increases (UPI), we determined that 7 of the 10 costliest US drug-price hikes [...]
Janet Woodcock to be Acting FDA Commissioner
Janet Woodcock is set to be the most powerful person at the FDA in less than a week. The veteran [...]
Amgen Tops Cost Watchdog’s Price Gougers List
In a top 10 ranking of the most egregious price gougers from 2019, Amgen’s Enbrel topped US cost watchdog ICER’s [...]
The American Public’s Priorities for the New President and Congress
In a post-election Politico/Harvard poll, an overwhelming 87% of the respondents indicated that “taking federal government action to lower prescription [...]
Webinar: Pathways to ISPOR Leadership
Tune in to the next installment of our leadership development series “Pathways to ISPOR Leadership” with special guest Mike Drummond, [...]
Department of Veterans Affairs Paid About Half as Much as Medicare Part D for Selected Drugs in 2017
A new analysis from the US Government Accountability Office shows that, in 2017, the Department of Veterans Affairs paid prescription drug prices [...]
Fierce JPM Week Partner Content Hub
This is a different approach to enabling our partners to share solutions and stories with you in a virtual environment. [...]
New Book Release by RJG Arnold: Pharmacoeconomics: From Theory to Practice
An understanding of the basic principles of pharmacoeconomics is essential if stakeholders in the healthcare arena hope to meet the [...]
New Data Show Retail Medicine Prices Fell in 2019
In 2019, retail prescription medicine prices declined by 0.4%, on average, according to National Health Expenditures (NHE) data from the Centers for Medicare & [...]
Pandemic Propels Health Systems to Mull Acquisitions, Partnerships
Nearly a year after the first confirmed case of COVID-19 in the U.S., some of the nation's largest health systems [...]
Gaps in Health Data are Barrier to Health Equity
COVID-19 has laid bare racial disparities in the United States health system. For example, COVID-19 cases among Native Hawaiian / [...]
Cerner Aspires to Build $1B Data Business in Pharma Market
Building on its acquisition of clinical research company Kantar Health, health IT giant Cerner is setting its sights on building [...]
[Podcast] Creating an HEOR Function Within Medical Affairs
In this episode of the MAPS Elevate podcast series, we explore Health Economics and Outcomes Research (HEOR), looking at why [...]
Implications of Price Transparency for Providers and Patients as New Rules Go into Effect
A new KFF analysis examines how new federal rules on price transparency for health services may affect patient decision-making and [...]
STaRT-RWE: Structured Template for Planning and Reporting on the Implementation of Real World Evidence Studies
In alignment with the International Council of Harmonization’s strategic goals, a public-private consortium has developed a structured template for planning [...]
Disparities in the Wage‑and‑Salary Earnings of HEOR Professionals
Using self-reported survey data collected in 2017 from a subset of HE/OR/MA professionals in the HealthEconomics.com global subscriber list, researchers [...]
2021 ARM – Call for Abstracts
Present your work at the premier forum for health services researchers, policy analysts, clinicians and community leaders using evidence and [...]
Specialty Generics Face Perverse Incentives In Medicare Part D
Whether specialty generics are cheaper to payers than their originator branded counterparts is partly a function of the level of [...]
Guest Blog Posts for the Journal of HEOR Website
The Journal of Health Economics and Outcomes Research is currently in the process of soliciting guest blog posts for the [...]
Race Rarely at Top of Patient’s Medical Record
Even though differences in health outcomes between Black and white people are well-established, a small survey finds that patients' race is not [...]
Drugmakers Raise Prices 3.3% in the New Year
This month pharmaceutical companies have increased list prices on hundreds of branded drugs -- mostly between 2-7% (with only a [...]
ICER Identifies Most Significant 2019 US Drug-Price Hikes
The Institute for Clinical and Economic Review (ICER) today published its latest report on Unsupported Price Increases (UPI) of prescription [...]
EQRx Scales Disruptive Model of Important New Medicines
EQRx, a company committed to developing and delivering important new medicines at lower prices, today announced that it has raised [...]